Literature DB >> 25557698

Ebola raises profile of blood-based therapy.

Declan Butler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25557698     DOI: 10.1038/517009a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

Authors:  Thomas C Luke; Edward M Kilbane; Jeffrey L Jackson; Stephen L Hoffman
Journal:  Ann Intern Med       Date:  2006-08-29       Impact factor: 25.391

2.  Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic.

Authors:  Joseph T Wu; Cheuk Kwong Lee; Benjamin J Cowling; Kwok Yung Yuen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 3.  The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis.

Authors:  John Mair-Jenkins; Maria Saavedra-Campos; J Kenneth Baillie; Paul Cleary; Fu-Meng Khaw; Wei Shen Lim; Sophia Makki; Kevin D Rooney; Jonathan S Nguyen-Van-Tam; Charles R Beck
Journal:  J Infect Dis       Date:  2014-07-16       Impact factor: 5.226

  3 in total
  2 in total

Review 1.  The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  PLoS Pathog       Date:  2015-04-23       Impact factor: 6.823

2.  Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates.

Authors:  Chad E Mire; Joan B Geisbert; Krystle N Agans; Emily P Thi; Amy C H Lee; Karla A Fenton; Thomas W Geisbert
Journal:  J Infect Dis       Date:  2016-08-28       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.